Document Detail

Racial/ethnic differences in the rates and correlates of HIV risk behaviors among drug abusers.
MedLine Citation:
PMID:  23414499     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: HIV infection disproportionately impacts minorities; yet research on racial/ethnic differences in the prevalence and correlates of HIV risk behaviors is limited.
OBJECTIVE: This study examined racial/ethnic differences in the rates of HIV risk behaviors and whether the relationship between HIV risk factors and HIV risk behaviors varies by race/ethnicity in clients participating in NIDA Clinical Trials Network trials.
RESULTS: The sample was 41% non-Hispanic White, 32% non-Hispanic Black, and 27% Hispanic (N = 2,063). HIV risk behaviors and measures of substance and psychosocial HIV risk factors in the past month were obtained. Non-Hispanic Blacks engaged in less HIV sexual risk behaviors overall than non-Hispanic Whites. While non-Hispanic Whites were the most likely to report any injection drug use, Hispanics engaged in the most HIV drug risk behaviors. Specific risk factors were differentially predictive of HIV risk behavior by race/ethnicity. Alcohol use severity was related to engaging in higher sex risk behaviors for non-Hispanic Blacks and Whites. Greater psychiatric severity was related to engaging in higher sex risk behaviors for non-Hispanic Whites. Drug use severity was associated with engaging in higher risk drug behaviors for non-Hispanic Whites and Hispanics with the magnitude of the relationship stronger for Hispanics.
CONCLUSIONS: These findings highlight the need for further research testing HIV risk prevention interventions within racial/ethnic groups to identify target behaviors or risk factors that are salient to inform HIV interventions.
SCIENTIFIC SIGNIFICANCE: The present study provides a systematic examination of race/ethnicity differences in the relationship between psychosocial risk factors and HIV risk behaviors.
Audrey J Brooks; Yuliya Lokhnygina; Christina S Meade; Jennifer Sharpe Potter; Donald A Calsyn; Shelly F Greenfield
Related Documents :
23049659 - Is back-projection methodology still relevant for estimating hiv incidence from nationa...
7219839 - Viral hepatitis among prisoners in norway.
23177679 - The impact of antenatal hiv diagnosis on postpartum childbearing desires in northern ta...
19907649 - Hiv/aids among inmates of and releasees from us correctional facilities, 2006: declinin...
23130209 - Malignant syphilis with human immunodeficiency virus infection.
22973469 - Molecular beacon probes-base multiplex nasba real-time for detection of hiv-1 and hcv.
17708599 - Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis c.
18256429 - Etiologic agent of an epidemic of cutaneous leishmaniasis in tolima, colombia.
22066129 - Social capital and women's reduced vulnerability to hiv infection in rural zimbabwe.
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions     Volume:  22     ISSN:  1521-0391     ISO Abbreviation:  Am J Addict     Publication Date:    2013 Mar-Apr
Date Detail:
Created Date:  2013-02-18     Completed Date:  2013-12-16     Revised Date:  2014-11-09    
Medline Journal Info:
Nlm Unique ID:  9208821     Medline TA:  Am J Addict     Country:  England    
Other Details:
Languages:  eng     Pagination:  136-47     Citation Subset:  IM    
Copyright Information:
Copyright © American Academy of Addiction Psychiatry.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
African Americans / psychology*
Alcohol Drinking / psychology
European Continental Ancestry Group / psychology*
HIV Infections / psychology*
Hispanic Americans / psychology*
Mental Disorders / diagnosis,  psychology
Middle Aged
Risk Factors
Severity of Illness Index
Substance Abuse, Intravenous / psychology
Unsafe Sex / psychology
Grant Support
K23 DA022297/DA/NIDA NIH HHS; K23 DA022297-02/DA/NIDA NIH HHS; K23 DA028660/DA/NIDA NIH HHS; K23 DA028660-01/DA/NIDA NIH HHS; K23DA022297/DA/NIDA NIH HHS; K23DA028660/DA/NIDA NIH HHS; K24 DA019855/DA/NIDA NIH HHS; K24 DA019855-04/DA/NIDA NIH HHS; K24DA 019855/DA/NIDA NIH HHS; N01DA‐5‐220/DA/NIDA NIH HHS; U10 DA013727/DA/NIDA NIH HHS; U10 DA013727/DA/NIDA NIH HHS; U10 DA015815/DA/NIDA NIH HHS; U10 DA015815-11/DA/NIDA NIH HHS; U10 DA015831/DA/NIDA NIH HHS; U10 DA020024/DA/NIDA NIH HHS; U10 DA13714/DA/NIDA NIH HHS; U10 DA15815/DA/NIDA NIH HHS; U10DA015831-09/DA/NIDA NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Brief motivational feedback may enhance treatment entry in veterans with comorbid substance use and ...
Next Document:  Differences between men and women in condom use, attitudes, and skills in substance abuse treatment ...